Well-child visit OS for multi-site pediatric groups that automates family intake, preventive outreach, and charge capture.

1. Fresh capital and operator-backed investors show pediatric workflow replacement has become a fundable, credible software category.
2. Fragmentation across records, billing, intake, scheduling, and family communication creates a clear opening for a cross-workflow product instead of another single-feature add-on.
3. FHIR-native interoperability plus embedded scribes and automated charge capture make specialty-specific deployment technically feasible without waiting for a full EMR replacement cycle.
4. Adoption across hundreds of pediatric providers in more than two dozen states suggests the market is already buying pediatric-native operational software, not just tolerating legacy systems.
5. Massive pediatric visit volume means even small gains in well-child completion, documentation time, and coding accuracy can compound into meaningful ROI quickly.

Catalyst. Develo's financing and reported multi-state adoption show pediatric practices are ready to buy specialty-specific operating software now, and FHIR-native interoperability with embedded scribes and charge capture makes deployment possible without a risky full-stack migration on day one.

The product connects to the pediatric EMR, practice-management system, billing stack, and family messaging tools to create a single longitudinal workflow for every child due for a well visit. Before the appointment, it sends the right age-specific forms and screeners, flags overdue vaccines or missing insurance data, and automatically recaptures missed or overdue visits into high-yield outreach queues. During the visit, it drafts the note, assembles school and camp paperwork, and recommends pediatric codes tied to documented counseling, screenings, and immunization events. After the visit, it routes families into follow-up messaging while giving managers a dashboard for recall gaps, checkout delays, and coding leakage by provider and location. The initial release is narrow and measurable: faster well-child prep, higher completion rates, and cleaner pediatric charge capture without forcing an immediate EMR rip-and-replace.

What's different. Existing pediatric EMRs manage the chart, and generic AI scribes manage the note, but neither owns the longitudinal well-child interval that starts with family prep and ends with coding, forms, and recall. This product is built around age-based pediatric logic: screeners, vaccine timing, caregiver communication, school forms, and pediatric charge rules in one workflow graph. That creates a proprietary dataset on how preventive visits convert into completed care, family retention, and clean claims across multi-site pediatric groups.

Jobs to be done

flowchart LR
  Buyer[COO / Practice admin] --> Pain[Fragmented well-child prep and revenue leakage]
  Pain --> Product[Well-child interval OS]
  Product --> Outcome[More completed visits and cleaner pediatric charges]

Executive takeaways

• The well-child interval is where pediatric operational pain is most concentrated because family prep, screeners, immunizations, documentation, and coding collide in one recurring workflow.
• Independent pediatric groups buy against measurable labor and revenue leakage, so the wedge must land as a workflow and margin tool rather than only an AI note assistant.
• Incumbent pediatric EHRs remain strong inside the chart, but no vendor clearly owns cross-system well-child orchestration from outreach through charge capture.
• The winning entry motion is low-risk overlay deployment first, then expansion into deeper workflow control after recall and charge-capture ROI is proven.

Market definition

U.S. software for independent pediatric groups that improves preventive visit preparation, completion, and revenue integrity without forcing a day-one rip-and-replace of the existing EHR stack.

Customer and buyer

The practical champion is the COO or practice administrator running multi-site operations; the economic buyer is the physician-owner, CEO, or COO who feels both staffing pressure and margin leakage; RCM and front-office leads are the functional stakeholders who must trust the workflow.

Buying triggers

• Quarterly revenue reviews that expose denial trends, no-shows, and thin-margin leakage create urgency to fix well-child workflows before adding headcount. [24][25][29]
• Overdue preventive care and Medicaid quality gaps become urgent when practices see W30 shortfalls or large lists of overdue 0-30 month visits. [6][7][9][32]
• Phone-heavy recall and intake workflows become intolerable when staff churn or multi-site growth makes manual outreach unscalable. [24][26][27][32]
• New pediatric coding complexity, especially around vaccine and counseling workflows, motivates buyers when lost charges are easy to quantify. [25][29]

Willingness to pay

Operators already spend to remove phone labor, rebook missed visits, and increase payment per visit; the clearest willingness-to-pay signal is not transparent list pricing but published ROI cases from pediatric RCM and intake overlays. [25][29][32][33]

Category dynamics

Growth signal 8.1% 2024 growth in physician and clinical services spending (demand-side proxy)

Validation signals

• Develo’s funding and reported multi-state provider adoption show that buyers will now consider pediatric-native workflow replacement.
• Office Practicum publishes pediatric RCM uplift metrics, indicating practices will pay for explicit revenue integrity improvement.
• Phreesia’s pediatric case shows measurable labor savings, self-scheduling uptake, and overdue well-visit reduction.
• Elation’s pediatric case studies show clinicians will adopt AI-powered documentation if it tangibly reduces after-hours charting.

Regulatory & technical constraints

• Adolescent privacy, proxy-access segmentation, and COPPA rules require state-aware consent and viewing logic rather than simple family-wide access.
• Information blocking and interoperability rules mean any data withholding or filtering must fit a valid exception rather than a vendor preference.
• Well-child automation must map to US Core patient, immunization, screening, and SMART backend patterns instead of proprietary objects wherever possible.
• Pediatric billing logic must handle preventive visits, developmental screenings, immunization workflows, and payer-specific reimbursement rules without overstepping clinician review.

The market breaks into four adjacent lanes: pediatric-native EHR incumbents with strong clinical depth, AI-forward primary-care EHRs adding pediatric workflows, ambient AI documentation vendors, and patient-engagement overlays that solve access but not clinical or billing orchestration. The gap is the well-child interval itself: no player clearly owns pre-visit screening, in-visit documentation, post-visit coding, and recall in one pediatric-specific loop.

Why incumbents do not win by default

• Pediatric EHRs. Pediatric-native incumbents are hard to displace inside the chart, but their strongest public evidence still centers on templates, billing, and vaccine workflows rather than AI-native interval orchestration.
• Primary-care EHRs. AI-forward EHRs can win smaller pediatric practices because documentation relief is real, but pediatric workflow depth remains lighter than specialty-native systems.
• Ambient AI scribes. Generic ambient AI vendors reduce charting time but do not own recall, family prep, vaccine logic, or pediatric coding workflows by default.
• Intake and engagement overlays. Access and recall overlays can prove labor and quality ROI, but they still need a clinical and revenue layer to close the well-child loop end to end.

This company should start as a well-child interval orchestration overlay for independent U.S. pediatric groups that already run the chart in incumbent pediatric EHRs but still coordinate outreach, intake, screeners, forms, and charge capture across separate tools and manual work. The first customer is a 15-30 provider group with 4-8 clinics where preventive visits are a large share of volume and back-to-school season, a revenue-cycle review, or a clinic acquisition exposes missed visits, incomplete prep, and coding leakage. The beachhead wedge is deliberately narrow: text-first family outreach, age-based digital intake and screening, note draft, and recommendation-mode pediatric charge capture for well visits, without forcing a day-one EMR replacement. This sequencing is faster to prove than a full pediatric operating system because buyers can measure prepared-visit rate, recovered overdue visits, checkout time, and accepted charge suggestions inside one recurring workflow. Go-to-market, product, and pricing should stay coupled around that same motion: a paid pilot for one clinic cluster, then an annual contract priced by provider seats and well-child volume once the workflow shows labor and revenue ROI. The strongest strategic advantage is not generic AI note-taking; it is pediatric interval logic that links Bright Futures cadence, vaccine readiness, screening completion, family communication, and billing evidence across sites. The main open questions are how concentrated compatible legacy stacks are in the first target states and how much charge leakage can be recovered in the beachhead segment, so the company should earn expansion only after integration speed and billing trust are proven in live pilots.

Problem

• Independent pediatric groups still run well-child visits across disconnected EMR, messaging, intake, scheduling, and billing tools, so staff chase forms, screeners, reminders, and vaccine readiness manually.
• That workflow fragmentation lowers preventive visit completion, slows checkout, and causes missed pediatric counseling, screening, and immunization-related charges in practices with little spare admin capacity.

Solution

• Deploy an overlay-first pediatric workflow layer that sends age-specific intake and screeners before the visit, flags overdue vaccines and missing insurance data, and recaptures overdue patients into prioritized outreach queues.
• During and after the visit, draft documentation, assemble routine forms, and suggest pediatric charge capture tied to documented screenings, counseling, and immunization events before expansion into broader practice workflows.

Why we win

• The product owns the well-child interval end to end, which incumbents, generic AI scribes, and patient-engagement overlays each address only in fragments.
• Cross-clinic data on prep completion, recall response, and evidence-linked charge capture can compound into a pediatric operations benchmark and revenue-integrity moat that is hard to reproduce quickly.

Milestones

flowchart LR
  Wedge[Well-child interval wedge] --> MVP[Read-first recall intake and coding MVP]
  MVP --> Proof[Prepared-visit and revenue proof points]
  Proof --> Expansion[Multi-workflow pediatric OS expansion]

Founding team

Experiment roadmap

Risk assessment

What must be true

• Independent pediatric groups will pay for an overlay workflow product before they are ready to rip out the incumbent pediatric EHR.
• The company can recover enough missed visits or charge leakage in well-child care to justify provider-seat pricing around the modeled spend level.
• Two to three integration patterns cover most early accounts without custom implementation destroying margins.
• Clinicians and billers trust recommendation-mode documentation and coding enough to use the product in live checkout workflows.
• The beachhead can expand into broader pediatric workflows after proof, rather than remaining a narrow recall tool with limited ACV.

Open diligence questions

• Which EHR, PM, messaging, and billing stacks appear most often in the first 20 target accounts?
• What percentage of well-child revenue leakage in the beachhead comes from missed screeners, counseling, vaccine, or combo-visit coding?
• How quickly can a pilot produce buyer-visible ROI in prepared visits, overdue-visit recovery, or cleaner claims?
• Where does the product win or lose against Develo, PCC, Office Practicum, and Phreesia in live evaluations?
• Which states should the company avoid first because adolescent privacy or proxy-access rules make deployment materially harder?

Model sanity

• Revenue engine. The base case is driven by growing production groups from 4 at Y1 exit to 26 at Y3 exit on a $108K blended annual contract value.
• Must go right. The first connector set must become repeatable fast enough that pilots convert into broader rollouts without gross margin stalling below 70%.
• Model breaks if. If pilot-to-production cycles stretch toward nine months or ARPU falls back toward the $96K downside case, the company likely needs additional capital before the next financing proof point.
• Next-round proof. The next round is justified by 12+ production groups, partner-sourced pipeline, and evidence that deployment time and audit-review burden are falling as accounts scale.

Scenarios

Sensitivity

flowchart LR
  Leads --> PaidPilots
  PaidPilots --> ProductionGroups
  ProductionGroups --> Revenue
  Revenue --> GrossProfit
  GrossProfit --> Cash

Flags: Base case still exits Y3 EBITDA negative, so the company likely raises its next round before full profitability. · Revenue concentration remains material because 26 modeled production groups still represent a small and relationship-driven customer base. · Gross margin assumes the first integration patterns stop behaving like custom services after the initial pilots and early multi-site rollouts. · CAC and churn are heuristic because there is no observed cohort history yet for this exact pediatric workflow product.

• Integration drag. Pediatric groups often run idiosyncratic EMR, practice-management, and messaging combinations that can slow onboarding and dilute early ROI. Mitigation: Start with the most common pediatric system combinations and offer a read-only rollout focused on recall, intake, and coding recommendations before deeper write-back.
• Clinical and billing trust gap. Providers and billers may resist AI-generated documentation or coding suggestions if they fear compliance errors or extra review burden. Mitigation: Keep clinicians in the approval loop, launch with recommendation mode, and tie adoption to measurable improvements in prepared visits, same-day completion, and claim cleanliness.
• Full-stack incumbent squeeze. Pediatric EMR vendors or emerging AI-native pediatric platforms could broaden into the same workflow once the economics become obvious. Mitigation: Win on the narrowest, highest-frequency well-child workflow first, then compound advantage through pediatric-specific benchmark data and multi-system orchestration incumbents do not natively control.